Physician profile
Scott Grabill
NPI 1659351096
$13,747.49
in general payments reported to CMS, 2019-2025
12 companies · $3,659 in 2025
The $3,659 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,398 · 2020: $2,708 · 2021: $459 · 2022: $26.08 · 2023: $164 · 2024: $334 · 2025: $3,659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,500 · Food and Beverage: $896 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,500.00 |
| Food and Beverage | $896.07 |
| Travel and Lodging | $760.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $5,233.14 | 2019 | |
| Stryker Corporation | $3,308.41 | 2019-2025 | Mako |
| Kyocera Medical Technologies, INC. | $2,659.42 | 2024-2025 | |
| Think Surgical, INC. | $760.36 | 2025 | |
| Depuy Synthes Sales INC. | $525.42 | 2019-2020 | |
| Medical Device Business Services, INC. | $482.35 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $448.41 | 2020-2023 | Rosa |
| Innovation Technologies INC | $109.33 | 2020 | |
| Encore Medical, Lp | $98.12 | 2025 | Djo Surgical |
| Smith+Nephew, INC. | $84.30 | 2019-2025 | Real Intelligence |
| Heraeus Medical, LLC. | $26.57 | 2025 | |
| Endo Pharmaceuticals INC. | $11.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Grabill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.